SPRINEXA Trademark

Trademark Overview

On Friday, March 14, 2008, a trademark application was filed for SPRINEXA with the United States Patent and Trademark Office. The USPTO has given the SPRINEXA trademark a serial number of 77422243. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 20, 2017. This trademark is owned by AstraZeneca AB. The SPRINEXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases, cardiovascular diseases, respiratory diseases, inflammation and infection, gastrointestinal diseases and central nervous system diseases
sprinexa

General Information

Serial Number77422243
Word MarkSPRINEXA
Filing DateFriday, March 14, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 20, 2017
Registration Number3801581
Registration DateTuesday, June 15, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases, cardiovascular diseases, respiratory diseases, inflammation and infection, gastrointestinal diseases and central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Trademark Events

Event DateEvent Description
Friday, January 20, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, June 15, 2010REGISTERED-PRINCIPAL REGISTER
Monday, May 10, 20101(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, May 7, 2010NOTICE OF ALLOWANCE CANCELLED
Monday, May 10, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 7, 2010TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 10, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2009PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2009NOTICE OF PUBLICATION
Monday, July 13, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 22, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 22, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 22, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 22, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, December 22, 2008INQUIRY TO SUSPENSION E-MAILED
Monday, December 22, 2008SUSPENSION INQUIRY WRITTEN
Wednesday, December 10, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, June 10, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 10, 2008LETTER OF SUSPENSION E-MAILED
Tuesday, June 10, 2008SUSPENSION LETTER WRITTEN
Tuesday, June 10, 2008EXAMINER'S AMENDMENT ENTERED
Tuesday, June 10, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 10, 2008EXAMINERS AMENDMENT E-MAILED
Tuesday, June 10, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, May 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 29, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 29, 2008NON-FINAL ACTION E-MAILED
Tuesday, April 29, 2008NON-FINAL ACTION WRITTEN
Monday, April 28, 2008ASSIGNED TO EXAMINER
Thursday, April 3, 2008PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, April 2, 2008ASSIGNED TO LIE
Friday, March 28, 2008PAPER RECEIVED
Wednesday, March 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

sprinexa diseases gastrointestinal infection central system nervous inflammation respiratory preparations treatment